Clinical trials are responsible for many of today’s life-saving procedures and treatments. But finding and enrolling in clinical trials can be difficult process, especially for Latinos who may experience language barriers or lack of information. In response to these challenges, the National Heart, Lung, and Blood Institute (NHLBI) recently updated their search engine to better help patients find and enroll in an NHBLI-sponsored clinical trial. Available in Spanish, interested participants can now browse for clinical trials by age group, condition, and location. The search engine also includes an overview of how clinical trials work, who can participate, and benefits, risks, and safety measures of trials. Diseases and conditions studied in NHBLI-sponsored clinical trials ...
Ever heard of donating biospecimens for research? When a person donates biospecimens—blood, fluid, or tissue samples—it gives researchers the opportunity to better understand, treat, and prevent medical conditions from cancer to Alzheimer's. Biospecimens are especially needed from Latinos, who suffer health disparities. "Latinos who donate biospecimens are heroes. Their contributions enable researchers to make medical discoveries and build new therapies to help millions of Latinos across the nation," said Dr. Amelie G. Ramirez, leader of the Salud America! Latino health equity program at the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio.
What are Biospecimens?
Biospecimens are materials from the human ...
Latinos are expected to comprise well over 25% of the U.S. population by 2050. But they face health disparities in eye health, diabetes, obesity, cancer, and more, endangering the future health of the nation. Dr. Amelie G. Ramirez, director of Salud America! at UT Health San Antonio, will explore the causes of these disparities in a virtual presentation, "A New Vision for Reaching Latinos for Systemic and Behavioral Change," at 2:45 p.m. ET, July 14, 2022, at the 11th Annual Focus on Eye Health National Summit led by Prevent Blindness. The overall event, which is free, is set for July 13-14, 2022. "Our efforts must address structural inequities — from a lack of healthcare access to unaffordable housing to experiences of discrimination to a lack of diversity among health care ...
“The good news is, we can’t kill you trying to save you. You showed up fit to fight.” Still in shock of recent events, Loriana Hernandez-Aldama tried to process the words of world-renowned oncologist Dr. Mark Levis. In such a short period of time in January 2014, her life had completely changed. Just a few days earlier, Loriana, a married mother and TV news anchor with a successful career in Austin and Dallas, Texas, was excitedly working with her fertility doctor to have another baby. But a precautionary blood test before a traditional embryo transfer revealed a disheartening diagnosis of AML Leukemia, an aggressive blood cancer. At the advice of her doctor and healthcare connections, she kissed her then 2-year-old son, Gabriel, goodbye, and boarded a plane to Johns ...
Latinos represent less than 10% of volunteers in cancer clinical trials. The lack of Latinos in clinical trials makes it harder for researchers to find treatments tailored for this group — which makes up 18.5% of the U.S. population and a diversity of heritages. This is why Drs. Amelie G. Ramirez and Patricia Chalela of UT Health San Antonio identified barriers and strategies to boost Latino representation in clinical trials in a new commentary in JCO Oncology Practice. It will take more than simply raising awareness of clinical trials to everyone. "To achieve equitable participation of Latinos and other underrepresented groups in clinical research, we need comprehensive approaches that address social and contextual barriers to participation," said Ramirez, leader of the ...
Oncologists who identify as Latino remain highly underrepresented in the workforce, according to a new report from the American Society of Clinical Oncology (ASCO). Although the percentage of Latino hematologists/oncologists has risen slightly over the past decade, from 4.1% in 2008 to 4.7% in 2018, Latino participation decreases at nearly every step in the path to becoming an oncologist, according to ASCO. “As a result, [Latino] patients are deprived the benefits of a representative workforce, such as improved access, enhanced culturally and linguistically competent care, and minimization of health disparities,” wrote Dr. Gladys Rodriguez of the START Center for Cancer Care in San Antonio, and her colleagues, in a recent study in JCO Oncology Practice. Why is this a ...
March is Colorectal Cancer Awareness Month. This cancer can affect anyone, but older Latinos may be particularly at risk. Know the facts about colorectal cancer, tips for screening and preventions, and how we can help researchers studying cancer.
What Should I Know About Colorectal Cancer?
Colorectal cancer is the disease of the colon and/or rectum. “Most cases of colorectal cancer occur in people ages 45 and older, but the disease is increasingly affecting younger people. Each year, about 150,000 Americans are diagnosed with this disease and more than 50,000 die,” according to the Colorectal Cancer Alliance. Many people in the early stages of colorectal cancer do not experience symptoms. However, symptoms might develop later on in the disease. Mayo Clinic lists ...
You are invited to join the Leukemia & Lymphoma Society (LLS) for a free virtual education program for patients and their families in Spanish. The event, "Los Estudios Clínicos: Los Mitos y Realidades / Clinical Trials: Myths and Realities," is set for 6 p.m. CST on March 15, 2022, via Zoom. Clinical trials are studies that help researchers learn more to help slow, manage, and treat cancer for current and future family members. But without Latino volunteers for clinical trials, the benefits may miss this group. Dr. Patricia Chalela, an associate professor at the Institute for Health Promotion Research at UT Health San Antonio, will help participants will learn about: ¿Qué es un estudio clínico? (What is a clinical trial?)
¿Cuál es la importancia de los estudios ...
With 1 in 3 Latinos facing a cancer diagnosis in their lifetime, UT Health San Antonio is hosting the 2022 Advancing the Science of Cancer in Latinos in-person conference on Feb. 23-25 at the Westin Riverwalk, 420 W. Market St, in San Antonio, Texas. The biennial conference is expected to draw 200 researchers, oncologists, physicians, community leaders, and students for an open dialogue on research advancements and actions to translate basic research into clinical best practices, effective community interventions, system-change advocacy, and professional training to eliminate cancer disparities in Latinos. The first Advancing the Science of Cancer in Latinos conferences in 2018 and 2020 united 80 guest speakers and over 600 attendees from 25 states, from D.C and New York to ...
